@article{77d761167a5e4daa934956d1b161c845,
title = "Gut virome profiling identifies a widespread bacteriophage family associated with metabolic syndrome",
abstract = "There is significant interest in altering the course of cardiometabolic disease development via gut microbiomes. Nevertheless, the highly abundant phage members of the complex gut ecosystem -which impact gut bacteria- remain understudied. Here, we show gut virome changes associated with metabolic syndrome (MetS), a highly prevalent clinical condition preceding cardiometabolic disease, in 196 participants by combined sequencing of bulk whole genome and virus like particle communities. MetS gut viromes exhibit decreased richness and diversity. They are enriched in phages infecting Streptococcaceae and Bacteroidaceae and depleted in those infecting Bifidobacteriaceae. Differential abundance analysis identifies eighteen viral clusters (VCs) as significantly associated with either MetS or healthy viromes. Among these are a MetS-associated Roseburia VC that is related to healthy control-associated Faecalibacterium and Oscillibacter VCs. Further analysis of these VCs revealed the Candidatus Heliusviridae, a highly widespread gut phage lineage found in 90+% of participants. The identification of the temperate Ca. Heliusviridae provides a starting point to studies of phage effects on gut bacteria and the role that this plays in MetS.",
keywords = "Bacteria/genetics, Bacteriophages/genetics, Cardiovascular Diseases, Ecosystem, Humans, Metabolic Syndrome, Virome/genetics, Virus, Alignment, Disease, Database, Microbial community",
author = "{de Jonge}, {Patrick A} and Koen Wortelboer and Scheithauer, {Torsten P M} and {van den Born}, {Bert-Jan H} and Zwinderman, {Aeilko H} and Nobrega, {Franklin L} and Dutilh, {Bas E} and Max Nieuwdorp and Hilde Herrema",
note = "Funding Information: The HELIUS study is conducted by the Amsterdam UMC, location AMC with the Public Health Service of Amsterdam. Both provided core financial support for HELIUS. The HELIUS study is also funded by research grants of the Dutch Heart Foundation (Hartstichting; 2010T084), the Netherlands Organization for Health Research and Development (ZonMw; 200500003), the European Integration Fund (EIF; 2013EIF013), and the European Union (Seventh Framework Programme, FP-7; 278901). We gratefully acknowledge the AMC Biobank for their support in biobank management and high-quality storage of collected samples. We are most grateful to the participants of the HELIUS study and the management team, research nurses, interviewers, research assistants and other staff who have taken part in gathering the data of this study. Funding Information: P.A.d.J. and T.P.M.S. were supported by a Senior Fellowship of the Dutch Diabetes Research Foundation (2019.82.004) to H.H. K.W. was supported by a Novo Nordisk Foundation CAMIT grant 2018 to M.N. B.E.D. was supported by the Netherlands Organization for Scientific Research (NWO) Vidi grant 864.14.004 and European Research Council (ERC) Consolidator grant 865694: DiversiPHI. The funders had no role in the study design, the collection, analysis, and interpretation of data, the writing of the report, and the decision to submit the article for publication. Publisher Copyright: {\textcopyright} 2022, The Author(s).",
year = "2022",
month = dec,
doi = "10.1038/s41467-022-31390-5",
language = "English",
volume = "13",
pages = "1--15",
journal = "Nature Communications",
issn = "2041-1723",
publisher = "Nature Publishing Group",
number = "1",
}